These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10413632)

  • 1. The use of free and fixed drug combinations to improve hypertension control in our populations.
    Chalmers J
    Eur Heart J; 1999 Aug; 20(15):1060-1. PubMed ID: 10413632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive therapy with fixed combinations].
    Holzgreve H
    Internist (Berl); 1996 Aug; 37(8):852-6. PubMed ID: 8964679
    [No Abstract]   [Full Text] [Related]  

  • 5. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic options--fixed dose combinations for treatment of hypertension. Report of the 3rd annual meeting of the American Society of Hypertension, New York, 1988].
    Fortschr Med Suppl; 1989; 76():1-15. PubMed ID: 2635682
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixed-dose combinations improve medication compliance: a meta-analysis.
    Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
    Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive agents--principles of combination drug therapy].
    Ruskoaho H
    Duodecim; 2000; 116(24):2826-30. PubMed ID: 12077888
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination antihypertensive drug therapy: a therapeutic option long overdue.
    Flack JM; Bledsoe K
    Am Fam Physician; 2000 May; 61(10):2974, 2977. PubMed ID: 10839550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guide for general practice. Much evidence favors broad use of fixed combinations].
    Scholze J
    Fortschr Med; 1998 May; 116(14):39-40. PubMed ID: 9648394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination therapy of hypertension. Various action principles--advantages of fixed combination preparations].
    Mann J; Unger T
    Fortschr Med; 1985 Nov; 103(44):58-9. PubMed ID: 4076997
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in the development of new combinations of blood pressure lowering drugs.
    Chalmers J; Harrap S; Narkiewicz K; Poulter N; Redon J; Zanchetti A; Mancia G
    J Hypertens; 2010 Dec; 28(12):2494-6. PubMed ID: 21266860
    [No Abstract]   [Full Text] [Related]  

  • 16. [New recommendations of the German Hypertension League for the drug treatment of hypertension].
    Zidek W; Düsing R; Haller H; Middeke M; Paul M; Schmieder R; Schrader J;
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2468-9. PubMed ID: 14628251
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose combination therapy in hypertension.
    Moser M; Prisant LM
    Am Fam Physician; 1997 Oct; 56(5):1275-6, 1279, 1282. PubMed ID: 9337752
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertension: pro and contra fixed combination therapy. Contra].
    Bönner G
    Fortschr Med; 1998 May; 116(14):38-9. PubMed ID: 9648393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension: pro and contra fixed combination therapy. Pro].
    Schrader J
    Fortschr Med; 1998 May; 116(14):37-8. PubMed ID: 9648392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.